<VariationArchive VariationID="1066367" VariationName="NM_000263.4(NAGLU):c.214_237dup (p.Ala72_Gly79dup)" VariationType="Duplication" Accession="VCV001066367" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-19" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1056427" VariationID="1066367">
      <GeneList>
        <Gene Symbol="LOC130060903" FullName="ATAC-STARR-seq lymphoblastoid silent region 8533" GeneID="130060903" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42536144" stop="42536553" display_start="42536144" display_stop="42536553" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="NAGLU" FullName="N-acetyl-alpha-glucosaminidase" GeneID="4669" HGNC_ID="HGNC:7632" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42536241" stop="42544449" display_start="42536241" display_stop="42544449" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="40687950" stop="40696466" display_start="40687950" display_stop="40696466" Strand="+" />
          </Location>
          <OMIM>609701</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000263.4(NAGLU):c.214_237dup (p.Ala72_Gly79dup)</Name>
      <CanonicalSPDI>NC_000017.11:42536480:GCGGCGCGGCGCGCGTGCGGGTGCGCGGC:GCGGCGCGGCGCGCGTGCGGGTGCGCGGCGCGGCGCGCGTGCGGGTGCGCGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42536480" stop="42536481" display_start="42536480" display_stop="42536481" variantLength="24" positionVCF="42536480" referenceAlleleVCF="G" alternateAlleleVCF="GGCGGCGCGGCGCGCGTGCGGGTGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="40688498" stop="40688499" display_start="40688498" display_stop="40688499" variantLength="24" positionVCF="40688498" referenceAlleleVCF="G" alternateAlleleVCF="GGCGGCGCGGCGCGCGTGCGGGTGC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.40688504_40688527dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.40688504_40688527dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.42536486_42536509dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.42536486_42536509dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011552.1" sequenceAccession="NG_011552" sequenceVersion="1" change="g.5554_5577dup">
            <Expression>NG_011552.1:g.5554_5577dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000263.4" sequenceAccession="NM_000263" sequenceVersion="4" change="c.214_237dup" MANESelect="true">
            <Expression>NM_000263.4:c.214_237dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000254.2" sequenceAccession="NP_000254" sequenceVersion="2" change="p.Ala72_Gly79dup">
            <Expression>NP_000254.2:p.Ala72_Gly79dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000263.3" sequenceAccession="NM_000263" sequenceVersion="3" change="c.214_237dup24">
            <Expression>NM_000263.3:c.214_237dup24</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1567890245" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000263.4(NAGLU):c.214_237dup (p.Ala72_Gly79dup) AND multiple conditions" Accession="RCV001377344" Version="6">
        <ClassifiedConditionList TraitSetID="23227">
          <ClassifiedCondition DB="MedGen" ID="C5569050">Charcot-Marie-Tooth disease axonal type 2V</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0086648">Mucopolysaccharidosis, MPS-III-B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000263.4(NAGLU):c.214_237dup (p.Ala72_Gly79dup) AND NAGLU-related disorder" Accession="RCV003416297" Version="4">
        <ClassifiedConditionList TraitSetID="90170">
          <ClassifiedCondition>NAGLU-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-12" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20852935</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22976768</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28751108</ID>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="90170" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70797" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NAGLU-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NAGLU-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="23227" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33609" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2V</ElementValue>
                <XRef Type="MIM" ID="616491" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2V</ElementValue>
                <XRef Type="MIM" ID="616491" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease axonal type 2V</ElementValue>
                <XRef ID="MONDO:0014665" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMT2V</ElementValue>
                <XRef Type="MIM" ID="616491" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17777" />
                <XRef ID="17777" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="447964" DB="Orphanet" />
              <XRef ID="C5569050" DB="MedGen" />
              <XRef ID="MONDO:0014665" DB="MONDO" />
              <XRef Type="MIM" ID="616491" DB="OMIM" />
            </Trait>
            <Trait ID="3221" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NAGLU DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IIIB (Sanfilippo B)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopoly-saccharidosis type 3B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sanfilippo syndrome B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetyl-alpha-d-glucosaminidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 3B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-III-B</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+IIIB/4916" DB="Genetic Alliance" />
                <XRef ID="59990008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS III B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS, TYPE IIIB</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0014" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS3B</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7072" />
                <XRef ID="7072" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type III (MPS III) is a multisystem lysosomal storage disease characterized by progressive central nervous system degeneration manifest as severe intellectual disability (ID), developmental regression, and other neurologic manifestations including autism spectrum disorder (ASD), behavioral problems, and sleep disturbances. Disease onset is typically before age ten years. Disease course may be rapidly or slowly progressive; some individuals with an extremely attenuated disease course present in mid-to-late adulthood with early-onset dementia with or without a history of ID. Systemic manifestations can include musculoskeletal problems (joint stiffness, contractures, scoliosis, and hip dysplasia), hearing loss, respiratory tract and sinopulmonary infections, and cardiac disease (valvular thickening, defects in the cardiac conduction system). Neurologic decline is seen in all affected individuals; however, clinical severity varies within and among the four MPS III subtypes (defined by the enzyme involved) and even among members of the same family. Death usually occurs in the second or third decade of life secondary to neurologic regression or respiratory tract infections.</Attribute>
                <XRef ID="NBK546574" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536183</ID>
                <ID Source="BookShelf">NBK546574</ID>
              </Citation>
              <XRef ID="79270" DB="Orphanet" />
              <XRef ID="C0086648" DB="MedGen" />
              <XRef ID="MONDO:0009656" DB="MONDO" />
              <XRef Type="MIM" ID="252920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7693101" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="32038215|NAGLU-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004117833" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The NAGLU c.214_237dup24 variant is predicted to result in an in-frame duplication (p.Ala72_Gly79dup). This variant was observed in at least 2 individuals with Mucopolysacharidosis IIIB (Bunge et al. 1999. PubMed ID: 9950362 Table 2; Valstar et al. 2010 PubMed ID: 20852935 Table 2). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAGLU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000263.3:c.214_237dup24</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NAGLU-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3100246" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11637785|MedGen:C4225306;C0086648" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001574651" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28751108</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20852935</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22976768</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects NAGLU function (PMID: 28751108). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 1066367). This variant has been observed in individual(s) with mucopolysaccharidosis type III (PMID: 20852935, 22976768). This variant is not present in population databases (gnomAD no frequency). This variant, c.214_237dup, results in the insertion of 8 amino acid(s) of the NAGLU protein (p.Ala72_Gly79dup), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAGLU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.40688498_40688499insGCGGCGCGGCGCGCGTGCGGGTGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225306" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0086648" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3100246" TraitType="Disease" MappingType="XRef" MappingValue="C0086648" MappingRef="MedGen">
        <MedGen CUI="C0086648" Name="Mucopolysaccharidosis, MPS-III-B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3100246" TraitType="Disease" MappingType="XRef" MappingValue="C4225306" MappingRef="MedGen">
        <MedGen CUI="C5569050" Name="Charcot-Marie-Tooth disease axonal type 2V" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7693101" TraitType="Disease" MappingType="Name" MappingValue="NAGLU-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="NAGLU-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

